TytoCare
TytoCare Names Adam Pellegrini Chief Executive Officer
TytoCare announced a leadership change on July 15, 2026. TytoCare named Adam Pellegrini Chief Executive Officer alongside a $25 million-plus growth round led by Insight Partners to scale its AI-first clinical enablement platform.
What changed
Adam Pellegrini was named Chief Executive Officer.
- Leader: Adam Pellegrini
- Role: Chief Executive Officer
- Effective: Not specified in the announcement
- Announcement date: July 15, 2026
Leadership background
Pellegrini brings more than two decades of experience at the intersection of digital health, consumer health technology, and large-scale clinical programs, the company said. The announcement did not name his prior employers or titles.
The mandate
TytoCare said that under Pellegrini it will pursue a clinical enablement model that embeds its AI-assisted examination capabilities into the care workflows of health systems, specialty programs, and payer-sponsored chronic disease management platforms. The company said the new financing will support expanding its AI clinical algorithms pipeline, deepening payer and health system partnerships, and accelerating go-to-market efforts.
Why this matters for GTM teams
Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.
Source and methodology
This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.
Primary source: TytoCare leadership announcement.
Related Reports
Asembia Appoints David Skomo Chief Executive Officer
Asembia appointed David Skomo as CEO, succeeding co-founder Lawrence Irene, and said he will focus on strengthening the company’s commercial capabilities, technology platform, and pharmacy services.
Lassila and Tikanoja Appoints Ari-Pekka Määttänen President and CEO
Lassila and Tikanoja appointed Ari-Pekka Määttänen, CEO of Fintoil Oy, as President and CEO from May 1, 2027, succeeding Eero Hautaniemi to lead the circular economy company’s next phase of growth.
Sciensus Appoints James Tugendhat Chief Executive Officer
Sciensus has appointed James Tugendhat OBE, most recently Group CEO of HC-One, as Chief Executive Officer, taking over from interim CEO Gordon Cox.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


